West Nile virus (WNV) is naturally maintained within
Culex mosquito-avian transmission cycles. 1 Culex tarsalis is the primary vector for WNV in North Dakota (ND). 2 Upon incidental infection, clinical symptoms in people may appear within three to 14 days and include fever, headache, and fatigue. In severe cases, WNV disease can progress to a neuroinvasive disease resulting in encephalitis or meningitis. Approximately one out of 140 infected people will develop neuroinvasive disease. 3 WNV emerged in New York City (NYC) in 1999 4 and has progressively spread across North America. Introduction of WNV into new regions of the United States has typically been characterized by a relatively low number of human cases during the initial year, followed by amplification to epidemic levels during the subsequent season. 5 ND experienced its first cases of WNV disease during 2002 (n17) followed by a 36-fold increase in cases during 2003 (n617). Presently, WNV continues to cause seasonal epidemics of neuroinvasive disease and febrile illness, which have been most dramatic in the central plains states, leading one to suspect that this region offers favorable conditions for its continued enzootic transmission. 2 In this article, we describe the epidemiology of WNV disease in ND, a highly epidemic state, six years following its first appearance in the state.
METHODS
In ND, human cases of WNV disease are reported directly to the North Dakota Department of Health (NDDoH) through a passive surveillance system. The majority of case reports originate from physicians' offices and laboratories. Cases are classified as either West Nile neuroinvasive disease (i.e., meningitis, encephalitis, or acute flaccid paralysis), West Nile fever, other clinical illness, or unspecified illness. Confirmed and probable cases of WNV disease were defined as described previously. 6 We analyzed information from cases of WNV disease (confirmed and probable) reported from August 2002 through December 2007. The NDDoH used a standardized case history form to collect demographic and clinical information about cases that met specific criteria for WNV disease. Variables collected through the surveillance system included race, gender, year of birth, date of onset, hospitalization status, and clinical symptoms. We estimated age by subtracting year of birth from year of disease onset for each case.
We defined a rural area according to the Rural-Urban Commuting Area (RUCA) coding (version 2.0) scheme. 7 We calculated annual incidence of neuroinva-sive disease as cases per 100,000 population using 2000 U.S. Census data (http://www.census.gov). We then conducted univariate and bivariate analyses using SAS ® version 9.1. 8 This study was approved by the University of South Dakota Institutional Review Board.
RESULTS
From August 2002 through December 2007, a total of 1,246 cases of WNV disease were reported to NDDoH. The median age at onset for cases was 47 years (range: 2-95 years). Men represented 58% (n725) of all cases. Seventy-six percent (n950) of cases were white, 3% (n30) were American Indian, and race was not reported for 21% (n266). Sixty-six percent (n821) of cases resided in a rural area. Dates of illness onset for all cases ranged from June 1 to November 7 during all six years of the study (Table 1) .
Of the 1,246 cases, 1,063 were classified as West Nile fever and 183 as West Nile neuroinvasive disease ( Table 1 ). The median age of people who were hospitalized for their disease was 58 years (range: 5-95 years). Not surprisingly, a greater proportion of the cases with West Nile neuroinvasive disease were hospitalized (95%) compared with West Nile fever cases (15%, p0.001). The neuroinvasive disease cases also reported a greater frequency of severe symptoms such as memory deficit (40%) and gait or balance difficulty (7%) than did the West Nile fever cases (11% memory deficit and 2% gait or balance difficulty, both p0.001). Rash was reported among 35% of neuroinvasive disease cases compared with 52% of West Nile fever cases (p0.001). Thirteen cases (1%) died of their disease. Among those who died with WNV disease, 77% (10/13) were male and the median age was 81 Year of report Incidence per 100,000
DISCUSSION
This article summarizes the epidemiologic characteristics of a large population of WNV cases identified through the NDDoH disease surveillance system. Among the case population, 15% experienced neuroinvasive disease. Bivariate analysis revealed that older age and male gender were significant predictors of developing neuroinvasive disease, which have been identified previously. 9 Residence in a rural area was also identified as a risk factor for developing neuroinvasive disease rather than West Nile fever. DeGroote et al. reported residence in a rural area as a risk factor for neuroinvasive disease among cases of WNV disease in Iowa, according to surveillance data. 10 This finding was in contrast to other studies that reported a predominance of urban/suburban occurrence. Our study finding may be explained in part by the large percentage of people living in rural areas in ND (52%) and the scarcity of aerial spraying of mosquito adulticide in rural areas compared with urban areas.
Limitations
One limitation of this study was that case reporting through ND is a passive surveillance system, dependent on the reporting of cases by health-care providers and laboratories to NDDoH. As a result, reporting to NDDoH is likely incomplete (leading to an underestimation of the true disease incidence) and may be variable by jurisdiction, and even over time within a jurisdiction. Reporting differences between West Nile neuroinvasive disease and West Nile fever also exist. Neuroinvasive disease case reporting is relatively complete compared with West Nile fever case reporting, largely because serious cases are more likely to be reported than mild cases. Presently, the majority of human WNV testing in ND is performed at the state public health laboratory; however, commercial testing kits are becoming more widely available for use in ND and other areas in the U.S.
